Annual Accounts Payable
$8.59 M
+$518.00 K+6.42%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual accounts payable is $8.59 million, with the most recent change of +$518.00 thousand (+6.42%) on December 31, 2023.
- During the last 3 years, ALXO annual accounts payable has risen by +$8.59 million (+214675.00%).
- ALXO annual accounts payable is now at all-time high.
Performance
ALXO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.89 M
-$255.00 K-3.13%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly accounts payable is $7.89 million, with the most recent change of -$255.00 thousand (-3.13%) on September 30, 2024.
- Over the past year, ALXO quarterly accounts payable has dropped by -$5.11 million (-39.30%).
- ALXO quarterly accounts payable is now -39.30% below its all-time high of $13.00 million, reached on September 30, 2023.
Performance
ALXO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ALXO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | -39.3% |
| 3 y3 years | +10000.0% | +53.7% |
| 5 y5 years | +1132.6% | +7.4% |
ALXO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.2% | -39.3% | +109.6% |
| 5 y | 5-year | at high | >+9999.0% | -39.3% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -39.3% | >+9999.0% |
ALX Oncology Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.89 M(-3.1%) |
| Jun 2024 | - | $8.15 M(+30.8%) |
| Mar 2024 | - | $6.23 M(-27.5%) |
| Dec 2023 | $8.59 M(+6.4%) | $8.59 M(-33.9%) |
| Sep 2023 | - | $13.00 M(+215.9%) |
| Jun 2023 | - | $4.12 M(-58.1%) |
| Mar 2023 | - | $9.83 M(+21.7%) |
| Dec 2022 | $8.07 M | $8.07 M(+37.3%) |
| Sep 2022 | - | $5.88 M(-32.3%) |
| Jun 2022 | - | $8.68 M(+69.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.13 M(+36.4%) |
| Dec 2021 | $3.76 M(>+9900.0%) | $3.76 M(+2.2%) |
| Sep 2021 | - | $3.68 M(-36.6%) |
| Jun 2021 | - | $5.81 M(-21.0%) |
| Mar 2021 | - | $7.35 M(>+9900.0%) |
| Dec 2020 | $4000.00(-99.9%) | $4000.00(-99.7%) |
| Sep 2020 | - | $1.42 M(-23.8%) |
| Jun 2020 | - | $1.86 M(-6.1%) |
| Mar 2020 | - | $1.99 M(-47.0%) |
| Dec 2019 | $3.75 M(+437.7%) | $3.75 M |
| Dec 2018 | $697.00 K | - |
FAQ
- What is ALX Oncology Holdings annual accounts payable?
- What is the all time high annual accounts payable for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual accounts payable year-on-year change?
- What is ALX Oncology Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly accounts payable year-on-year change?
What is ALX Oncology Holdings annual accounts payable?
The current annual accounts payable of ALXO is $8.59 M
What is the all time high annual accounts payable for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual accounts payable is $8.59 M
What is ALX Oncology Holdings annual accounts payable year-on-year change?
Over the past year, ALXO annual accounts payable has changed by +$518.00 K (+6.42%)
What is ALX Oncology Holdings quarterly accounts payable?
The current quarterly accounts payable of ALXO is $7.89 M
What is the all time high quarterly accounts payable for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly accounts payable is $13.00 M
What is ALX Oncology Holdings quarterly accounts payable year-on-year change?
Over the past year, ALXO quarterly accounts payable has changed by -$5.11 M (-39.30%)